MMED
MiniMed Group, Inc. Common StockHealthcare · $5.4B market cap
Verdict
We can't put a fair value on MMED right now. It has lost money in each of its last 3 years, and our valuation needs recent profits to project from.
Business quality
1 of 5 clear the 10% bar. What are the Big Five?
Follow MMED
Track it on your watchlist and see the full analysis. Free.
Create a free accountInsider activity
Since Oct 28, 2026: no open-market purchases and 1 other filing (stock awards, tax withholding and similar). Why purchases matter
Other filings
Questions about MMED
Are insiders buying MMED?
Since Oct 28, 2026: no open-market purchases and 1 other filing (stock awards, tax withholding and similar).
How can I check MMED's value myself?
Use the free Sticker Price calculator, already filled with MMED's numbers. Change the growth, P/E or required return and see what you'd pay. Open the calculator →
Similar stocks · Medical - Equipment & Services
About MiniMed Group, Inc. Common Stock
MiniMed Group, Inc. specializes in designing, producing, and distributing a broad spectrum of medical technologies and solutions aimed at effective diabetes management. The company's diverse portfolio features essential tools like insulin pumps, continuous glucose monitoring (CGM) systems, infusion sets, specialized software platforms, and various supplementary accessories. These innovations are crafted to enable both patients and healthcare providers to accurately monitor and precisely regulate blood glucose levels. The enterprise was established in 1983 by Alfred E. Mann and is currently headquartered in Northridge, California.
Medical - Equipment & Services
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of Oct 30, 2026. How the Payback Price works